Literature DB >> 27684428

An Acute Retinal Model for Evaluating Blood Retinal Barrier Breach and Potential Drugs for Treatment.

Hao Wu1, Ana R Rodriguez2, Bernd W Spur2, Venkat Venkataraman3.   

Abstract

A low-cost, easy-to-use and powerful model system is established to evaluate potential treatments that could ameliorate blood retinal barrier breach. An inflammatory factor, histamine, is demonstrated to compromise vessel integrity in the cultured retina through positive staining of IgG outside of the blood vessels. The effects of histamine itself and those of candidate drugs for potential treatments, such as lipoxin A4, are assessed using three parameters: blood vessel leakage via IgG immunostaining, activation of Müller cells via GFAP staining and change in neuronal dendrites through staining for MAP2. Furthermore, the layered organization of the retina allows a detailed analysis of the processes of Müller and ganglion cells, such as changes in width and continuity. While the data presented is with swine retinal culture, the system is applicable to multiple species. Thus, the model provides a reliable tool to investigate the early effects of compromised retinal vessel integrity on different cell types and also to evaluate potential drug candidates for treatment.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27684428      PMCID: PMC5092011          DOI: 10.3791/54619

Source DB:  PubMed          Journal:  J Vis Exp        ISSN: 1940-087X            Impact factor:   1.355


  22 in total

1.  Amyloid-beta, the retina, and mouse models of Alzheimer disease.

Authors:  Zhiqun Tan; Jian Ge
Journal:  Am J Pathol       Date:  2010-02-18       Impact factor: 4.307

2.  An in vitro blood-brain barrier model combining shear stress and endothelial cell/astrocyte co-culture.

Authors:  Yukio Takeshita; Birgit Obermeier; Anne Cotleur; Yasuteru Sano; Takashi Kanda; Richard M Ransohoff
Journal:  J Neurosci Methods       Date:  2014-05-22       Impact factor: 2.390

3.  Inhibition of dehydroascorbic acid transport across the rat blood-retinal and -brain barriers in experimental diabetes.

Authors:  Akito Minamizono; Masatoshi Tomi; Ken-ichi Hosoya
Journal:  Biol Pharm Bull       Date:  2006-10       Impact factor: 2.233

4.  Brain-reactive autoantibodies prevalent in human sera increase intraneuronal amyloid-β(1-42) deposition.

Authors:  Robert G Nagele; Peter M Clifford; Gilbert Siu; Eli C Levin; Nimish K Acharya; Min Han; Mary C Kosciuk; Venkat Venkataraman; Semah Zavareh; Shabnam Zarrabi; Kristin Kinsler; Nikhil G Thaker; Eric P Nagele; Jacqueline Dash; Hoau Y Wang; Andrew Levitas
Journal:  J Alzheimers Dis       Date:  2011       Impact factor: 4.472

5.  Corticosteroids inhibit VEGF-induced vascular leakage in a rabbit model of blood-retinal and blood-aqueous barrier breakdown.

Authors:  Jeffrey L Edelman; David Lutz; Marisol R Castro
Journal:  Exp Eye Res       Date:  2005-02       Impact factor: 3.467

6.  Palmitate transport through the blood-retina and blood-brain barrier of rat visual system during aging.

Authors:  M Alberghina; G Lupo; C D Anfuso; F Moro
Journal:  Neurosci Lett       Date:  1993-02-05       Impact factor: 3.046

Review 7.  Pro-resolving lipid mediators are leads for resolution physiology.

Authors:  Charles N Serhan
Journal:  Nature       Date:  2014-06-05       Impact factor: 49.962

Review 8.  Blood-retinal barrier.

Authors:  José Cunha-Vaz; Rui Bernardes; Conceição Lobo
Journal:  Eur J Ophthalmol       Date:  2011       Impact factor: 2.597

9.  Effects of topical indomethacin, bromfenac and nepafenac on lipopolysaccharide-induced ocular inflammation.

Authors:  Claudio Bucolo; Giuseppina Marrazzo; Chiara Bianca Maria Platania; Giovanni Luca Romano; Filippo Drago; Salvatore Salomone
Journal:  J Pharm Pharmacol       Date:  2014-02-12       Impact factor: 3.765

10.  Vascular pathology and blood-brain barrier disruption in cognitive and psychiatric complications of type 2 diabetes mellitus.

Authors:  Yonatan Serlin; Jaime Levy; Hadar Shalev
Journal:  Cardiovasc Psychiatry Neurol       Date:  2011-02-17
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.